Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy

  • Julio D. Duarte*
  • , Cameron D. Thomas
  • , Craig R. Lee
  • , Rachel Huddart
  • , Jose A. G. Agundez
  • , Jordan F. Baye
  • , Andrea Gaedigk
  • , Teri E. Klein
  • , David E. Lanfear
  • , Andrew A. Monte
  • , Mohamed Nagy
  • , Matthias Schwab
  • , C. Michael Stein
  • , Chakradhara Rao S. Uppugunduri
  • , Ron H. N. van Schaik
  • , Roseann S. Donnelly
  • , Kelly E. Caudle
  • , Jasmine A. Luzum
    • *Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

35 Citations (Scopus)
65 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science